Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus
NCT04046133
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Anal Cancer Stage III A
Anal Cancer Stage III B
Interventions
DRUG:
Pembrolizumab
Sponsor
Cardiff University